<DOC>
	<DOCNO>NCT00574925</DOCNO>
	<brief_summary>The primary objective study investigate whether eradication treatment Helicobacter pylorus follow therapy esomeprazole total 8 week extends time relapse patient gastroesophageal reflux disease ( GERD ) . A relapse define two consecutive symptom score Eraflux questionnaire within 14 day equal critical value 25 . The secondary objective 1 . To compare time relapse two H. pylorus positive study group H. pylori negative control group 2 . To compare pattern inflammation atrophy two H. pylorus positive treatment group naturally H. pylorus negative control group relapse . 3 . All objective analyze efficacy subset per-protocol patient broken effective H. pylori-eradication . Secondary endpoint analyze follow parameter interaction : 1 . Treatment : Eradicated , Non-eradicated , Hp-negative control 2 . Esophagitis study start : grade 0 , A/B C/D 3 . Gender 4 . Alcohol intake 5 . NSAID/ASA intake ( histological result ) - Trial medicinal product</brief_summary>
	<brief_title>Study Assess Management Strategies Use Esomeprazole ( Nexium ) Helicobacter Pylori Infected Patients</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Inclusion criterion : For inclusion study subject must fulfill follow criterion : 1 . Patients age 18 70 year . 2 . Chronic symptom ( &gt; 8 week ) suggestive GERD , define Table 2 without reflux esophagitis grade AD ( Los Angeles classification ) 3 . Indication endoscopy due GERD symptom give 4 . Written inform consent Table 2 : Lead GERD criterion For inclusion study , follow lead GERD criterion hold : At least one symptoms heartburn regurgitation . At least 8 week ongoing symptom . At least 3 time week . At least moderate intensity , correspond light impairment daily life occasional need drug . Exclusion criterion : Any follow regarded criterion exclusion study : 1 . Severe organic esophageal disease reflux esophagitis ( e.g . carcinoma , esophageal stenosis ) . 2 . Gastric duodenal ulcer 3 . Patients visible Barrett 's mucosa ; histological confirmation require exclusion 4 . History previous esophageal gastric surgery 5 . Alcohol drug abuse 6 . Severe organic psychiatric disease 7 . Pregnancy lactation 8 . Women childbearing potential medically accept contraceptive measure use 9 . Contraindication amoxicillin , clarithromycin esomeprazole ( Nexium ) 10 . Need concomitant medication could interfere investigational product ( substrate CYP3A4 ) 11 . Suspected confirm poor compliance 12 . Participation clinical study within 8 week prior enrollment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>H. pylorus</keyword>
</DOC>